TY - JOUR
T1 - Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma
AU - Kumar, R. K.
AU - Herbert, C.
AU - Yang, M.
AU - Koskinen, A. M.L.
AU - McKenzie, A. N.J.
AU - Foster, P. S.
PY - 2002
Y1 - 2002
N2 - Background: Interleukin-13 is believed to be important in asthmatic inflammation and airway hyper-reactivity. Objective: To investigate the role of IL-13 in chronic asthma, using an improved experimental model of asthma that reproduces most of the morphological features of the human disease. Methods: BALB/c mice or gene-targeted mice deficient in their ability to produce IL-13 or the IL-4 receptor α-chain (IL-4Rα) were sensitized to ovalbumin and exposed to aerosolized antigen for 30 min/day on 3 days/week for 6 weeks. Intraepithelial eosinophils, accumulation of chronic inflammatory cells in the airway wall, subepithelial fibrosis, epithelial hypertrophy and numbers of mucous cells were quantified histomorphometrically. Airway hyper-reactivity (AHR) to a cholinergic agonist was assessed by barometric plethysmography. Results: Compared with wild-type animals, IL-13-/- mice exhibited diminished accumulation of eosinophils and chronic inflammatory cells, as well as reduced subepithelial fibrosis, epithelial hypertrophy and mucous cell hyperplasia (P < 0.01 for all comparisons). In contrast, AHR was still demonstrable in IL-13-/-mice. In IL-4Rα-/- mice the inflammatory response, subepithelial fibrosis and AHR were similar to wild-type mice, although the receptor-deficient mice had significantly less epithelial hypertrophy and mucous cell hyperplasia. Conclusion: These results imply a critical role for IL-13 in accumulation ofintraepithelial eosinophils in chronic asthma, as well as in epithelial and subepithelial remodelling. In addition, they suggest that in chronic asthma, IL-13 may be capable of signalling via a pathway that does not involve IL-4Rα.
AB - Background: Interleukin-13 is believed to be important in asthmatic inflammation and airway hyper-reactivity. Objective: To investigate the role of IL-13 in chronic asthma, using an improved experimental model of asthma that reproduces most of the morphological features of the human disease. Methods: BALB/c mice or gene-targeted mice deficient in their ability to produce IL-13 or the IL-4 receptor α-chain (IL-4Rα) were sensitized to ovalbumin and exposed to aerosolized antigen for 30 min/day on 3 days/week for 6 weeks. Intraepithelial eosinophils, accumulation of chronic inflammatory cells in the airway wall, subepithelial fibrosis, epithelial hypertrophy and numbers of mucous cells were quantified histomorphometrically. Airway hyper-reactivity (AHR) to a cholinergic agonist was assessed by barometric plethysmography. Results: Compared with wild-type animals, IL-13-/- mice exhibited diminished accumulation of eosinophils and chronic inflammatory cells, as well as reduced subepithelial fibrosis, epithelial hypertrophy and mucous cell hyperplasia (P < 0.01 for all comparisons). In contrast, AHR was still demonstrable in IL-13-/-mice. In IL-4Rα-/- mice the inflammatory response, subepithelial fibrosis and AHR were similar to wild-type mice, although the receptor-deficient mice had significantly less epithelial hypertrophy and mucous cell hyperplasia. Conclusion: These results imply a critical role for IL-13 in accumulation ofintraepithelial eosinophils in chronic asthma, as well as in epithelial and subepithelial remodelling. In addition, they suggest that in chronic asthma, IL-13 may be capable of signalling via a pathway that does not involve IL-4Rα.
KW - Allergy
KW - Cytokines
KW - Eosinophils
KW - In vivo animal models
KW - Inflammation
UR - http://www.scopus.com/inward/record.url?scp=0035987319&partnerID=8YFLogxK
U2 - 10.1046/j.1365-2222.2002.01420.x
DO - 10.1046/j.1365-2222.2002.01420.x
M3 - Article
SN - 0954-7894
VL - 32
SP - 1104
EP - 1111
JO - Clinical and Experimental Allergy
JF - Clinical and Experimental Allergy
IS - 7
ER -